Last checked at 24 Apr 2020 07:00
Feedback plc
Grant of Options
London, UK, 24 April 2020 - Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that it has granted a total of 19,000,000 options to subscribe for new ordinary shares in the Company under the Company's EMI Share Option Scheme ("Employee Options") to certain of its directors and employees, as detailed below.
The Employee Options are being issued in lieu of salary increases and bonuses this year, to support staff retention and to further align overall reward with increasing shareholder value.
The Employee Options are exercisable at a price of 1.2 pence per share and will vest, subject to the grantees' continued employment with the Company, over three years as to one-third on the first anniversary of the date of grant, one-third on the second anniversary of date of grant and one-third on the third anniversary of date of grant. The Employee Options expire 10 years after date of grant. The aggregate 19,000,000 Employee Options represent 3.52% of the Company's issued share capital.
The Employee Options are being granted to the following directors and persons discharging managerial responsibilities ("PDMRs"):
- Rory Shaw, Non-executive Chairman and Chief Medical Officer of the Company, has been granted 5,000,000 Employee Options;
- Lindsay Melvin, Finance Director of the Company, has been granted 1,500,000 Employee Options; and
- Mike Hayball, Stephen Brown, Nick Mayhew and Stephen McAteer have each been granted 2,000,000 Employee Options.
Following the grant of the Employee Options, the Company has a total of 60,330,829 options to subscribe for ordinary shares in the Company in issue, representing 11.17% of the Company's issued share capital at the date of this announcement.
The exercise price of 1.2 pence per share reflects the price at which the Company last completed an equity fundraise in August 2019 and represents a premium of 17.65 per cent to the closing share price on the last trading day before this announcement. The Company's 30 day average closing mid-price is 0.62 pence per share and the closing share price on the last trading day before this announcement was 1.02 pence per share.
The FCA notifications, made in accordance with the requirements of the EU Market Abuse Regulation, are appended below.
Enquiries:
Feedback plc Rory Shaw, Chairman Tom Oakley, CEO Lindsay Melvin, CFO | +44 (0)1954 718072 IR@fbk.com |
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai | +44 (0)20 3328 5656 |
Peterhouse Corporate Finance Ltd (Joint Broker) Lucy Williams / Duncan Vasey | +44 (0)20 7469 0936 |
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes | +44 20 3815 8880 |
Instinctif Partners Melanie Toyne-Sewell / Phillip Marriage | +44 (0)20 7457 2020 feedbackplc@instinctif.com |
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.
Feedback has launched BleepaTM, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on BleepaTM, see www.bleepa.com.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Rory Shaw | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Chairman | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in consideration of payment of fees
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 23 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Lindsay Melvin | ||||
2 | Reason for the notification | |||||
a) | Position/status | Finance Director | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for Ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in accordance with the Company's EMI Share Option Scheme
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 23 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Mike Hayball | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director of Feedback Medical Limited (Person Discharging Managerial Responsibilities) | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for Ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in consideration of payment of fees
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 23 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Stephen Brown | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director of Feedback Medical Limited (Person Discharging Managerial Responsibilities) | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for Ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in consideration of payment of fees
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 23 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
|
| |||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Nick Mayhew | ||||
2 | Reason for the notification | |||||
a) | Position/status | Manager at Feedback Medical Limited (Person Discharging Managerial Responsibilities) | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for Ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in consideration of payment of fees
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 6 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Stephen McAteer | ||||
2 | Reason for the notification | |||||
a) | Position/status | Manager at Feedback Medical Limited (Person Discharging Managerial Responsibilities) | ||||
b)
| Initial notification /Amendment | Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Feedback plc | ||||
b) | LEI | 213800UGOF2GT2U2RV90 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code | Options to subscribe for Ordinary Shares of 0.25p each
Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
| ||||
b) | Nature of the transaction | Issue of options to subscribe for Ordinary Shares in consideration of payment of fees
| ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | N/A
| ||||
e) | Date of the transaction | 23 April 2020 | ||||
f) | Place of the transaction | Outside a trading venue | ||||